AI Driven Drug Discovery Summit 2022

Join Cerebras at this Event. Cerebras' Natalia Vassilieva will be speaking.

Join us

Want to learn more? Schedule a meeting with our team and learn more about the CS-2.

Join us

000 days 00 hours 00 minutes 00 seconds


Natalia Vassilieva

Director of Product, Machine Learning

Cerebras session date: August 16, 2-2:30 PM
Cerebras session: More Powerful AI Technology Will Transform Drug Discovery
  • To transform the speed, sophistication and safety of drug discovery, researchers must be able to train complex models, using huge domain-specific datasets, in hours so they can run many experiments to test their hypotheses. Today each run can take weeks, which is a major roadblock
  • These capabilities are now in reach, thanks to recent advances in computational biology and ultra-powerful AI accelerator hardware
  • We will present exciting work on cell-specific modelling with both genetic and epigenetic data using a deep language model trained orders of magnitude faster than with traditional infrastructure


If You're Doing Pharma and Life Sciences AI Research Without a Cerebras System, You're Doing it Wrong

Cerebras AI accelerator systems make it possible to train complex models using huge datasets at the speed of science.


Health & Pharma

Cerebras is removing roadblocks to biomedical research, drug discovery, and data-driven healthcare at leading institutions across the globe. We offer cluster-scale deep learning acceleration in a single, easy-to-program device, so your researchers can focus on medical innovation, not on working around the limitations of traditional computing systems.

Learn more

Context is Everything: Why Maximum Sequence Length Matters

GPU-Impossible™ sequence lengths on Cerebras systems may enable breakthroughs in Natural Language Understanding, drug discovery and genomics.